 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1xu0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
1 term
|
 |
|
Biological process
|
protein homooligomerization
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
102:651-655
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Prion protein NMR structures of chickens, turtles, and frogs.
|
|
L.Calzolai,
D.A.Lysek,
D.R.Pérez,
P.Güntert,
K.Wüthrich.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The NMR structures of the recombinant prion proteins from chicken (Gallus
gallus; chPrP), the red-eared slider turtle (Trachemys scripta; tPrP), and the
African clawed frog (Xenopus laevis; xlPrP) are presented. The amino acid
sequences of these prion proteins show approximately 30% identity with mammalian
prion proteins. All three species form the same molecular architecture as
mammalian PrPC, with a long, flexibly disordered tail attached to the N-terminal
end of a globular domain. The globular domain in chPrP and tPrP contains three
alpha-helices, one short 3(10)-helix, and a short antiparallel beta-sheet. In
xlPrP, the globular domain includes three alpha-helices and a somewhat longer
beta-sheet than in the other species. The spatial arrangement of these regular
secondary structures coincides closely with that of the globular domain in
mammalian prion proteins. Based on the low sequence identity to mammalian PrPs,
comparison of chPrP, tPrP, and xlPrP with mammalian PrPC structures is used to
identify a set of essential amino acid positions for the preservation of the
same PrPC fold in birds, reptiles, amphibians, and mammals. There are additional
conserved residues without apparent structural roles, which are of interest for
the ongoing search for physiological functions of PrPC in healthy organisms.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Sequence alignment of hPrP, chPrP, tPrP, and xlPrP,
where hPrP represents "mammalian-type PrP." At the top is the
residue numbering for hPrP, which is used throughout this
manuscript, i.e., insertions and deletions in chPrP, tPrP, and
xlPrP required for maximal coincidence with hPrP are not
consecutively numbered. In this alignment, the amino acids shown
in red are identical in all four PrPs, and the ones displayed in
blue are identical in chPrP, tPrP, and hPrP. The black box
identifies the segment containing polypeptide repeats (see text)
for which no individual alignments were attempted. The GPI
attachment site is identified with a green box, and the
glycosylation sites (asparagine attachment site and nearest-next
threonine/serine) is identified with light blue boxes. The
orange boxes indicate segments with higher than average sequence
conservation that do not have an apparent stabilizing role in
the PrP fold, and might thus be conserved for functional
reasons. These include the polypeptide segment 23-42 with the
N-terminal signaling-peptide cleavage site, which has been
suggested to be the signaling-peptide for reinternalization of
PrP (36), a Src homology 3 (SH3)-binding motif of residues
100-110 (37, 38), the segment 113-128 representing a predicted
transmembrane helix (39, 40), and the segment 146-155 in hPrP,
chPrP, and tPrP that shows similarity to the laminin 2-chain
(see text). The pink boxes indicate segments with high amino
acid identity that appear to be needed for the stability of the
"PrP-fold" (see text). At the bottom, the regular secondary
structures in the globular domain of the four proteins are
indicated. The sequence alignment was performed interactively so
as to align a maximal number of identical residues. For the
globular domain (121-230), the alignment was also based on
visual inspection of the three-dimensional structures. In chPrP,
the insertion at the end of helix 2 was divided into two
segments to properly align the glycosylation site 197-199.
|
 |
Figure 2.
Fig. 2. NMR structures of the globular domains of hPrP,
chPrP, tPrP, and xlPrP. The polypeptide backbone fold for the
residues 126-230 (see Fig. 1 for the sequence numbering used)
and the core side chains with <20% solvent accessibility are
shown for each species, as a superposition of the 20 conformers
used to represent the NMR structure. The following side chains
are included (see Fig. 1 for the sequence information): 141, 149
(only for chPrP and xlPrP), 150 (only for hPrP and xlPrP), 161,
162, 164 (only for xlPrP), 175, 176, 179, 180 (only for hPrP,
chPrP, and tPrP), 183, 184, 205, 206, 209, 210, 213, 214, and
218. (A) hPrP (side chains shown in pink). (B) chPrP (side
chains shown in blue). (C) tPrP (side chains shown in green).
(D) xlPrP (side chains shown in yellow).
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.R.Brown
(2011).
Prions and manganese: A maddening beast.
|
| |
Metallomics, 3,
229-238.
|
 |
|
|
|
|
 |
C.A.Tabrett,
C.F.Harrison,
B.Schmidt,
S.A.Bellingham,
T.Hardy,
Y.H.Sanejouand,
A.F.Hill,
and
P.J.Hogg
(2010).
Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
|
| |
Biochem J, 428,
169-182.
|
 |
|
|
|
|
 |
H.F.Ji,
and
H.Y.Zhang
(2010).
beta-sheet constitution of prion proteins.
|
| |
Trends Biochem Sci, 35,
129-134.
|
 |
|
|
|
|
 |
J.Kumar,
S.Sreeramulu,
T.L.Schmidt,
C.Richter,
J.Vonck,
A.Heckel,
C.Glaubitz,
and
H.Schwalbe
(2010).
Prion protein amyloid formation involves structural rearrangements in the C-terminal domain.
|
| |
Chembiochem, 11,
1208-1213.
|
 |
|
|
|
|
 |
V.Cecarini,
L.Bonfili,
M.Cuccioloni,
M.Mozzicafreddo,
M.Angeletti,
and
A.M.Eleuteri
(2010).
The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities.
|
| |
Apoptosis, 15,
1322-1335.
|
 |
|
|
|
|
 |
W.C.Guest,
N.R.Cashman,
and
S.S.Plotkin
(2010).
Electrostatics in the stability and misfolding of the prion protein: salt bridges, self energy, and solvation.
|
| |
Biochem Cell Biol, 88,
371-381.
|
 |
|
|
|
|
 |
A.Pietropaolo,
L.Muccioli,
C.Zannoni,
and
E.Rizzarelli
(2009).
Conformational preferences of the full chicken prion protein in solution and its differences with respect to mammals.
|
| |
Chemphyschem, 10,
1500-1510.
|
 |
|
|
|
|
 |
D.B.O'Sullivan,
C.E.Jones,
S.R.Abdelraheim,
M.W.Brazier,
H.Toms,
D.R.Brown,
and
J.H.Viles
(2009).
Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.
|
| |
Protein Sci, 18,
410-423.
|
 |
|
|
|
|
 |
G.Schmitt-Ulms,
S.Ehsani,
J.C.Watts,
D.Westaway,
and
H.Wille
(2009).
Evolutionary descent of prion genes from the ZIP family of metal ion transporters.
|
| |
PLoS One, 4,
e7208.
|
 |
|
|
|
|
 |
R.A.Moore,
L.M.Taubner,
and
S.A.Priola
(2009).
Prion protein misfolding and disease.
|
| |
Curr Opin Struct Biol, 19,
14-22.
|
 |
|
|
|
|
 |
R.C.Wiggins
(2009).
Prion stability and infectivity in the environment.
|
| |
Neurochem Res, 34,
158-168.
|
 |
|
|
|
|
 |
S.H.Bae,
G.Legname,
A.Serban,
S.B.Prusiner,
P.E.Wright,
and
H.J.Dyson
(2009).
Prion proteins with pathogenic and protective mutations show similar structure and dynamics.
|
| |
Biochemistry, 48,
8120-8128.
|
 |
|
|
|
|
 |
S.Hornemann,
B.Christen,
C.von Schroetter,
D.R.Pérez,
and
K.Wüthrich
(2009).
Prion protein library of recombinant constructs for structural biology.
|
| |
FEBS J, 276,
2359-2367.
|
 |
|
|
|
|
 |
A.Pietropaolo,
L.Muccioli,
R.Berardi,
and
C.Zannoni
(2008).
A chirality index for investigating protein secondary structures and their time evolution.
|
| |
Proteins, 70,
667-677.
|
 |
|
|
|
|
 |
C.J.Sigurdson
(2008).
A prion disease of cervids: chronic wasting disease.
|
| |
Vet Res, 39,
41.
|
 |
|
|
|
|
 |
J.Shearer,
P.Soh,
and
S.Lentz
(2008).
Both Met(109) and Met(112) are utilized for Cu(II) coordination by the amyloidogenic fragment of the human prion protein at physiological pH.
|
| |
J Inorg Biochem, 102,
2103-2113.
|
 |
|
|
|
|
 |
L.Ronga,
P.Palladino,
G.Saviano,
T.Tancredi,
E.Benedetti,
R.Ragone,
and
F.Rossi
(2008).
Structural characterization of a neurotoxic threonine-rich peptide corresponding to the human prion protein alpha 2-helical 180-195 segment, and comparison with full-length alpha 2-helix-derived peptides.
|
| |
J Pept Sci, 14,
1096-1102.
|
 |
|
|
|
|
 |
A.D.Steele,
S.Lindquist,
and
A.Aguzzi
(2007).
The prion protein knockout mouse: a phenotype under challenge.
|
| |
Prion, 1,
83-93.
|
 |
|
|
|
|
 |
A.De Simone,
A.Zagari,
and
P.Derreumaux
(2007).
Structural and hydration properties of the partially unfolded states of the prion protein.
|
| |
Biophys J, 93,
1284-1292.
|
 |
|
|
|
|
 |
A.Pastore,
and
A.Zagari
(2007).
A structural overview of the vertebrate prion proteins.
|
| |
Prion, 1,
185-197.
|
 |
|
|
|
|
 |
C.W.Lennon,
H.D.Cox,
S.P.Hennelly,
S.J.Chelmo,
and
M.A.McGuirl
(2007).
Probing structural differences in prion protein isoforms by tyrosine nitration.
|
| |
Biochemistry, 46,
4850-4860.
|
 |
|
|
|
|
 |
H.F.Ji,
H.Y.Zhang,
and
L.L.Chen
(2007).
Why are prion diseases precluded by non-mammals?
|
| |
Trends Biochem Sci, 32,
206.
|
 |
|
|
|
|
 |
L.Ronga,
P.Palladino,
G.Saviano,
T.Tancredi,
E.Benedetti,
R.Ragone,
and
F.Rossi
(2007).
NMR structure and CD titration with metal cations of human prion alpha2-helix-related peptides.
|
| |
Bioinorg Chem Appl, 0,
10720.
|
 |
|
|
|
|
 |
M.Premzl,
and
V.Gamulin
(2007).
Comparative genomic analysis of prion genes.
|
| |
BMC Genomics, 8,
1.
|
 |
|
|
|
|
 |
M.S.Shamsir,
and
A.R.Dalby
(2007).
Beta-sheet containment by flanking prolines: molecular dynamic simulations of the inhibition of beta-sheet elongation by proline residues in human prion protein.
|
| |
Biophys J, 92,
2080-2089.
|
 |
|
|
|
|
 |
J.W.Chen,
P.Romero,
V.N.Uversky,
and
A.K.Dunker
(2006).
Conservation of intrinsic disorder in protein domains and families: II. functions of conserved disorder.
|
| |
J Proteome Res, 5,
888-898.
|
 |
|
|
|
|
 |
L.Ingrosso,
B.Novoa,
A.Z.Valle,
F.Cardone,
R.Aranguren,
M.Sbriccoli,
S.Bevivino,
M.Iriti,
Q.Liu,
V.Vetrugno,
M.Lu,
F.Faoro,
S.Ciappellano,
A.Figueras,
and
M.Pocchiari
(2006).
Scrapie infectivity is quickly cleared in tissues of orally-infected farmed fish.
|
| |
BMC Vet Res, 2,
21.
|
 |
|
|
|
|
 |
L.Ronga,
B.Tizzano,
P.Palladino,
R.Ragone,
E.Urso,
M.Maffia,
M.Ruvo,
E.Benedetti,
and
F.Rossi
(2006).
The prion protein: Structural features and related toxic peptides.
|
| |
Chem Biol Drug Des, 68,
139-147.
|
 |
|
|
|
|
 |
M.Eiden,
A.Buschmann,
L.Kupfer,
and
M.H.Groschup
(2006).
Synthetic prions.
|
| |
J Vet Med B Infect Dis Vet Public Health, 53,
251-256.
|
 |
|
|
|
|
 |
N.Piening,
P.Weber,
T.Högen,
M.Beekes,
H.Kretzschmar,
and
A.Giese
(2006).
Photo-induced crosslinking of prion protein oligomers and prions.
|
| |
Amyloid, 13,
67-77.
|
 |
|
|
|
|
 |
D.La Mendola,
R.P.Bonomo,
G.Impellizzeri,
G.Maccarrone,
G.Pappalardo,
A.Pietropaolo,
E.Rizzarelli,
and
V.Zito
(2005).
Copper(II) complexes with chicken prion repeats: influence of proline and tyrosine residues on the coordination features.
|
| |
J Biol Inorg Chem, 10,
463-475.
|
 |
|
|
|
|
 |
P.Stańczak,
D.Valensin,
P.Juszczyk,
Z.Grzonka,
G.Valensin,
F.Bernardi,
E.Molteni,
E.Gaggelli,
and
H.Kozłowski
(2005).
Fine tuning the structure of the Cu2+ complex with the prion protein chicken repeat by proline isomerization.
|
| |
Chem Commun (Camb), 0,
3298-3300.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|